Background: Breastmilk (BM) may participate in driving gut barrier function and im-
| INTRODUC TI ON
Breastfeeding has health benefits in various pathophysiologic conditions (eg, diarrhea episodes, respiratory infection, or malocclusion in children), but its effect on allergy prevention is still controversial. 1, 2 This may be explained by heterogeneity in breastfeeding duration, but also by interindividual variations in breastmilk (BM) composition.
In this context, BM content in immunomodulatory components may be critical, notably during the neonatal period. Early BM allows the transfer of immunomodulatory nutrients, various growth and angiogenic factors, and immune factors such as immune cells, antibodies, and cytokines. [3] [4] [5] [6] [7] [8] [9] [10] All these components will modulate the growth, differentiation, maturation, function, and angiogenesis of the neonate organs, notably of the gastrointestinal tract and associated immune system. Immaturity of the neonatal digestive tract and the presence of antiproteases in BM may reduce the degradation of all these factors and allow their absorption by the neonate in an active form, notably in the first days of life when permeability is increased. 11, 12 Early BM may then be considered more as providing immune and trophic stimuli than as a nutritional source.
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Despite the potential role of early BM in neonate immunity and intestinal homeostasis, there are currently very few studies analyzing its composition in immune and growth factors, with only a limited number of components analyzed. 10, [14] [15] [16] [17] [18] [19] [20] [21] The impact of the concentrations of early BM components on child atopy or allergy has also been poorly analyzed. 10, 22 Moreover, all these studies provide often conflicting results due to small sample size and to differences in the analytical tools used, in the day of collection considered and the way of sampling (foremilk vs hindmilk), and in the population analyzed (reviewed in Ref. 
| MATERIAL S AND ME THODS

| Study population
The EDEN mother-child study is a prospective cohort for investigation of the pre-and post-natal determinants of child growth, development, and health. The study is described in detail elsewhere. 23 In brief, 2002 pregnant women were recruited in two
French university hospitals (Poitiers and Nancy) and the children's health was followed up for 5 years using yearly questionnaires.
Data collected during pregnancy and at birth include socio-demographic variables, maternal dietary pattern during the last trimester of pregnancy, maternal smoking, gestational diabetes, parental anthropometric measurements, and newborn characteristics (gender, gestational age, birthweight). 24 Mothers were defined as atopic if they reported at least one medical diagnosis of allergic disease (asthma, eczema, allergic rhinitis, food allergy). Among other biologic samples collected, one BM sample was collected per mother during the maternity stay.
Maternal dietary patterns were previously identified by principal component analysis. 25 For each participant, a score was calculated for each identified pattern, a higher score indicating a higher adherence of the women to this pattern. By construction, scores are independent and standardized. In the present analysis, we considered the "Healthy pattern," characterized by high positive loading for vegetables, high-fat dairy products, pods and peas, fish and whole grain cereals, and the "Western pattern," characterized by high positive loading for snacks, cakes, processed meat, French fries, soda, sandwich, and chocolate.
"FA cases" in children correspond to doctor-diagnosed FA reported by the parents at least at one yearly follow-up within the first 5 years of life. In line with a recent cohort-based study, 26 FA cases were defined by a positive answer to the question "Has a medical doctor diagnosed a food allergy in your child?" Food-specific IgE measurement or food challenge was not included in the protocol.
Corresponding data were censored by age at the last follow-up.
| Subcohort and casecohort design
| Subcohort
We first randomly selected 150 mother-child dyads (full-term) from each center (ie, Nancy and Poitiers) for which BM samples were ini- 
| Casecohort design
All the other FA cases identified in the whole cohort, for which BM samples were available, were added to the subcohort. Forty-six additional FA cases were therefore added. More additional cases were from Nancy, due to the larger number of samples collected and still available in this center. The casecohort then contains 318 samples and includes 72 FA-reported cases.
Description of the mother and environmental and birth characteristics of the subcohort and casecohort is provided in Table S1 .
| BM collection
The collection was performed by manual expression after feeding the newborn (hindmilk), at any time of day and anytime during the maternity stay, following a standardized protocol. The collection day was categorized as day 1 (day of birth) to days >6. Samples were collected in sterile tubes and kept at +4°C until their transfer to the laboratory where they were aliquoted and transferred to −80°C. The time between collection and freezing was recorded for all samples.
Sixty percent of the samples were frozen within 24 hours, the third quartile for sample freezing at −80°C was 42 hours, but the maximal delay observed was 141 hours. However, no association between component concentrations and time between sampling and freezing was observed for all the measured factors (not shown).
| Sample pre-treatment for analysis
After thawing, samples were centrifuged (2000 x g, 20 minutes, +4°C). The clear defatted fraction was collected and immediately analyzed. In order to control the recovery and to assess the dilution to be used in the different assays, preliminary experiments were performed using a pool of colostrum from 3 mothers obtained commercially (CliniSciences, Nanterre, France). All samples from the cohort were then analyzed randomly and blindly.
| Cytokine and IgG assays
We selected BM components based on their potential role as growth factor and/or immune stimulating/regulating activity in the neonate. 
| Statistical analysis
Descriptive statistics and associations of early BM components with maternal characteristics were conducted on the subcohort (263 non-selected samples). Associations between immune and growth factor concentrations and incidence of food allergy were estimated thanks to the casecohort design (ie, with additional FA cases, n = 318 samples including 72 FA-reported cases). All statistics procedures, including corrections for multiple testing, 27,28 are described in details in online repository file.
| RE SULTS
| Concentrations of the immune and growth components in early breastmilk
We first classified growth and immune components depending on the range of measured concentrations. As summarized in Table 1 , the concentrations were the highest for antibodies, chemokines CXCL1, CXCL10, and CCL2, and the growth factor EGF. Other growth factors and chemokines and all the IL were found at lower concentrations (<50 pg/mL for most of the IL). We provide concentrations of all the BM components at each day of collection in supplementary files, depending on their physiologic role: antibodies (Table S2) , growth factors (Table S3) , chemokines (Table S4) , T helper-related or regulatory cytokines (Table S5) , and proinflammatory/proliferation cytokines (Table S6) . Depending on the sampling date, 50% to 75%
and 50% to 58% of the samples did not show detectable levels of CCL3 and IL-3, respectively. IL-12p70, IL-4, IL-5, and TNFβ were not detectable in a few samples (up to 5 out of 263), and IL-9 was not detectable in 16 samples. All the other components were detectable in all the samples.
| Overall day-to-day variations of the concentrations of the immune components and growth factors in early BM
Supervised multivariate statistical analysis evidenced a progres- CCL5 was the chemokine the most affected over time, globally decreasing as early as day 3 ( Figure 2D ). The only affected interleukin was IL-15, which slightly decreased over time ( Figure 2E ).
In order to consider all the samples independently of their sampling date in the following analyses, we performed data adjustment on the day of collection. TA B L E 1 Range of concentrations of the components analyzed in breastmilk collected from day 2 to day 6 F I G U R E 1 PLS-DA analysis of the samples based on the day of collection. A supervised analysis of the weighted centering data set was performed using PLS-DA, where dependent (Y) variable-that is, the variable used for classification, corresponds to the sampling date.
Concentration range Factors
Corresponding days of collection are represented using a color code. A total of 100 permutations were performed for model validation 
| Association between growth/immune components in early BM and maternal, environmental, or birth-associated characteristics
Multiple linear regressions revealed relations between the concentrations of some early BM components and parameters such as maternal atopy, age at first pregnancy, BMI before pregnancy, smoking during pregnancy, place of residence (Poitiers or Nancy), C-section, educational level, and primiparity (Table 2) .
However, these relations were far less numerous after applying a false discovery rate (FDR)-controlling procedure that takes into account multiple testing. 28 For example, the positive association between maternal atopy and concentrations of EGF and IL-4 was no longer significant after the FDR procedure.
The most related factor was primiparity, which was associated with higher concentrations of all IgG isotypes and IgM, growth factors Flt3L and TGFα, chemokines CXCL8 and CX3CL1, Th1 cytokine IL-12p40, and proinflammatory cytokine IFNα2. The less related factors were a high BMI before pregnancy (Flt-3L), smoking during pregnancy (IgG2, IgM), and age at first pregnancy (TGFβ1, TGFβ2).
The association between maternal diet ("healthy" vs "Western") during the last trimester of pregnancy and concentrations of early BM components was also assessed. Selected data from the subcohort (n = 237 out of 263; Table S1 ) were considered, corresponding to data for which maternal dietary scores were available.
Concentrations of some immune and growth factors were associated with the dietary pattern, but this was no longer significant after the FDR procedure (Table 3) . We then performed further analyses using only samples from Poitiers where significantly more pronounced differences in dietary patterns were seen. The concentrations of 8 factors were then shown to be negatively
F I G U R E 2 TGFβ1 (A), VEGF (B), TGFα (C), CCL5 (RANTES, D)
, and IL-15 (E) concentrations in breastmilk samples collected from day 2 to day 6. Concentrations are expressed in pg/mL. Each point represents an individual BM sample, and mean ± SEM is indicated for each sampling day. Bars indicate significant differences between specified sampling dates, using least square means and adjustment for multiple comparison test (Bonferroni test): *: P < 0.05, **: P < 0.01, ***: P < 0.001 associated with the Western dietary pattern even after the FDRcontrolling procedure (FGF-2, Flt3-L, IL-12p40, IL-12p70, sCD40L, IFNα2, IL-3, IL-1RA, TNFβ), all of them except one (TNFβ) belonging to cluster 1.
Inversely, the most affected components in early BM were Flt-3L
(high BMI, primiparity, diet), IgG2 (place of residence, smoking, primiparity), and IFNα2 (living in Nancy, primiparity, diet).
| Associations between growth/immune component concentrations in early BM and food allergy in early childhood
Finally, thanks to the casecohort design, higher concentrations of G-CSF, IL 12p40, IL-1β CXCL10, TNFβ and IL-2 in early BM were first associated with parental reports of doctor-diagnosed FA, but this was still significant only for CXCL10, TNFβ and IL-2 after the FDR correction (Table 4 ). The association with CXCL10 was significant only among children with no maternal history of allergy (P for interaction = 0.0009).
| D ISCUSS I ON
Up to 50 immune and growth factor components were detected in almost all the 263 early BM samples analyzed. Early BM should then be considered as a strong provider of immune and trophic stimuli.
Data for around 30 of the factors analyzed were not available to date, and our study provides new reference values. Data obtained for other factors were globally in agreement with published data obtained in colostrum, 8, 16, 19, 20, 29, 30 although some discrepancies were observed, for example, for TGFβ, IgG4, and CCL2 concentrations. 15, 20, 29 These differences may stem from variations in methodologies and standards provided by different manufacturers that are not normalized using an international reference.
Besides providing the widest quantitative analysis of cytokines, growth factors, and antibodies in early BM, and although samples
were not collected at different time points from the same mothers, the sample size was large enough to provide evidence of a global variation of immune and growth factor concentrations in BM in the first days of life. However, we observed that this relies on few components, F I G U R E 3 Correlation heatmap and cluster dendrogram for concentrations of the 50 components in early BM. Automatic hierarchical clustering was performed using Heatmap.2 algorithm (ggplot2 package from R) without modification of R script and with optimized inertia break between classes. Clusters were then defined visually from the heatmap generated. Heatmap of the distance matrix is shown with the color code corresponding to Spearman correlation values. Color coding corresponds to values between −1 (blue) and +1 (red), corresponding to negative and positive correlation, respectively TNFa  IL-10  IL-1RA  IL-1a  IL-1b  GSC-F  IL-6  CCL2  IgG4  IL-7  CX3CL1  PDF-AA  TGFb3  EGF  TGFb2  TGFb1  CCL11  CCL7  IgG1  IL-5  IL-13  IL-2  IL-4  IgG2  IgM  IL-15  TGFa  CXCL8  IgG3  CCL22  PDGF-BB  CCL5  IFNg  CXCL10  IgA  IL-3  IL-17  TNFb  IFNa2  Flt-3L  IL-12p40  GM-CSF  FGF-2  IL-12p70  sCD40L  IL-9  CXCL1  VEGF   CCL4  CCL3  TNFa  IL-10  IL-1RA  IL-1a  IL- Selected data from the subcohort (n = 115 from Nancy and n = 122 from Poitiers), for which maternal dietary practices were available, were used in a multiple linear regression model analyzing each immune or growth factor, previously adjusted for sampling day by the residual method. Positive correlation: higher concentrations associated with the analyzed factor. Components impacted by the parameters considered were first identified using multiple linear regression testing *: 0.01 < P<0.05, **: 0.001 < P<0.01, ***P < 0.001. The component concentrations still significantly affected after the false discovery rate procedure (P value cutoff of 0.1) are shown in bold characters.
Characteristics Condition
Impacted immune or growth factors
Positive association Negative association
Maternal atopy
suggesting that the passage from colostrum to transition milk (days 3-4) impacted the immune composition of BM only modestly.
However, we performed data adjustment that allowed integration of all samples into further analysis, independently of these temporal variations. We analyzed the inter-relationships between concentrations of early BM components and found several clusters of positively or negatively correlated components. Some of them were quite surprising, for example, the negative correlation between
IgA and TGFβ1/2, which could reflect a compensation phenomenon to speed up IgA production in neonates when low levels of maternal IgA are provided. We also assessed the association of some components with maternal, environmental, or birth-associated parameters (Table 2 ). We clearly observed that the concentrations of components from the core cluster 1 were negatively associated with a "Western" dietary pattern during the last trimester of pregnancy.
Immune information transmitted to the neonate is then associated with the eating habits of the mother and probably more globally with her associated lifestyle. Altogether, this may partially explain the impact of a Western lifestyle on overall health, participating in maladaptation of individuals to their environment from early life and predisposing them to "modern" diseases. Primiparity was also positively related to numerous component concentrations in BM. This can be placed in the context of the birth-order effect on disease risk.
As an example, primiparity was associated with a higher cow's milk allergy prevalence in a case-control study nested in the Finnish population. 31 This birth-order effect may rely on different in utero programming of the child's immune system, as evidenced by a reduced anti-inflammatory profile of cord blood T cells from first-born infants following polyclonal activation. 32 In continuity with this observation, we now suggest that early BM composition in growth and immune components would not be the same for the first-born and for her/his subsequent brothers/sisters, which should be further confirmed in samples obtained from the same brothers and sisters.
Some studies show an association of maternal atopy with con- CD40-and IL-4-induced B-cell proliferation and IgE synthesis. 46 The latter study suggested that the role of TNFβ in the induction of allergic reaction and of atopic state would have to be considered, a hypothesis that our present results also highlight. The positive association between CXCL10, IL-2, and TNFβ concentrations and FA development clearly need further validation in other cohorts, and the mechanisms involved merit further investigations in experimental models.
We did not assess other immunologic components such as the cellular and complement systems, nor factors such as human milk oligosaccharides or microbiota, which may also greatly impact the gut barrier and immunity in neonates. We are aware of the other limitations of our study, the most important being that no longitudinal sampling was performed and that FA cases rely on parental reporting of a medical diagnosis of FA, that is, no laboratory tests or food challenges were additionally performed. Our results then need to be confirmed by further studies with repeated BM collection throughout the first week of life and a validated method to confirm food allergies. However, we should highlight the breadth of the analysis performed (50 immune and growth factors) and the number of samples analyzed, which yield the widest analysis hitherto of immune and growth factors in early BM. Moreover, those samples were obtained in a mother-child cohort also collecting a comprehensive set of data on the maternal environment and habits, and on the child. Although we focus here on FA in childhood, all the data we generated will be available in the cohort to be related to other child health outcomes and global development.
In conclusion, thanks to samples and information collected in the EDEN mother-child cohort, we show that immune and growth factor concentrations in early BM, and thus potentially the immune, 
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